Cargando...

抗CD19 CAR-T细胞治疗难治复发B细胞肿瘤10例临床分析

OBJECTIVE: To investigate the outcomes of anti-CD19 CAR-T cell for relapsed and refractory B cell malignancies. METHODS: Ten patients with relapsed and refractory B cell acute lymphocytic leukemia (B-ALL) and non-Hodgkin's lymphoma (NHL), diagnosed in the Department of Hematology of Peking Univ...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Zhonghua Xue Ye Xue Za Zhi
Formato: Artigo
Idioma:Inglês
Publicado: Editorial office of Chinese Journal of Hematology 2018
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7342922/
https://ncbi.nlm.nih.gov/pubmed/30032559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.06.003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!